InsiderTrades

Form 4 for ROIV Roivant Sciences Ltd.

Accepted 2025-12-29 00:00:00 ET · period of report 2025-12-23 · accession 0001140361-25-046788 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2025-12-29 2025-12-24 ROIV Torti Frank Pres, Vant COB J - Other $22.47 -64.9K 13.85M -0.5% -$1.46M
2025-12-29 2025-12-24 ROIV Torti Frank Pres, Vant COB G - Gift $0.00 -110.5K 13.74M -0.8% $0
2025-12-29 2025-12-23 ROIV Torti Frank Pres, Vant COB A - Grant $22.45 +175.4K 13.91M +1% +$3.94M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Shares 2025-12-24 J D 64,891 $22.47 13,847,036 D — — (F2) The price reported in column 4 is a weighted average price. These Common Shares were sold in multiple transactions at prices ranging from $22.45 to $22.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. (F3) Represents a sale of Common Shares only to cover estimated taxes due in connection with the exchange described in footnote 1.
2 Common Common Shares 2025-12-24 G D 110,489 $0.00 13,736,547 D — —
3 Common Common Shares 2025-12-23 A A 175,380 $22.45 13,911,927 D — — (F1) Represents Common Shares received in exchange for shares of a subsidiary of the Issuer. The per Common Share price represents the closing price of the Issuer's Common Shares on the date of the exchange.